Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol ? C, bisphenol ? C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, it offers contract manufacturing services.
The company was incorporated in 1984 and is headquartered in Mumbai, India.
AartiDrugs was established in 1982 by Mr Pradip K.Hokmingkarmi and the company started manufacturing Pharmaceutical and fine chemicals in 1984. Aarti Drugs has been promoted by the HoshingKarmi family, one of India's most illustrious names in the industrial field.
Aarti Drugs is a vertically integrated company with a range of products in the therapeutic areas of Cardiovascular, Anti-Infective, Anti-Diabetic, Gastrointestinal, Nutritional, Anti-Cancer, Dermatology and Ophthalmic.
The company has a vast distribution network and its products are exported to over 30 countries. Aarti Drugs has a comprehensive manufacturing infrastructure with six manufacturing facilities located in various states in India. The company has achieved many milestones in its journey and is now one of the leading players in the Indian pharmaceutical industry.
AartiDrugs was listed on National Stock Exchange of India Limited in 2003.
The company turnover reach Rs.1500 Crore in 2019.
Our mission is to provide quality products to our customers and be recognised globally for innovation, quality and deivery.
Our vision is to be a global leader in the field of Active Pharmaceutical Ingredients and Specialty Chemicals.
https://in.investing.com/equities/aarti-drugs-ltd
https://www.comparably.com/companies/vision/mission
https://www.crunchbase.com/organization/aarti-drugs
https://finance.yahoo.com/quote/AARTIDRUGS.NS/
https://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/aartidrugs/AD
https://www.screener.in/company/AARTIDRUGS/
https://economictimes.indiatimes.com/aarti-drugs-ltd/stocks/companyid-10801.cms
https://www.linkedin.com/company/aarti-drugs-limited/
